查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566779

抗菌塑胶市场：按添加剂、按塑胶、按最终用途：2024-2033 年全球机会分析和产业预测

Antimicrobial Plastics Market By Additive , By Plastic By End-Use : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 250 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年抗菌塑胶市场规模为431亿美元，预计2033年将达874亿美元，2024年至2033年复合年增长率为7.4%。

抗菌塑胶是注入添加剂和被覆剂的人造材料，旨在抑制微生物的生长。这些塑胶中使用的常见抗菌剂包括银离子、铜、锌和有机化合物，例如三氯生和季铵化合物。这些药物破坏微生物的细胞功能，导致其破坏和生长抑制。抗菌塑胶的主要优点包括降低感染风险、延长产品保存期限和保持清洁。抗菌塑胶可最大限度地减少表面和产品上的微生物污染，提高安全性和卫生性。

消费者对卫生和安全意识的提高，特别是在COVID-19大流行之后，增加了对抗菌产品的需求，这是推动全球抗菌塑胶市场成长的关键因素。此外，医院相关感染发生率的惊人增长迫使医疗机构在医疗设备、设备和表面上采用抗菌塑料，以降低感染率。 2018 年发表在《医院感染杂誌》上的一项研究表明，在医院环境中使用抗菌表面可以将医院相关感染的发生率降低高达 30%。考虑到仅在美国每年就有约 170 万名患者遭受医院相关感染，这项减少是显着的。此外，包括医院、诊所和医疗设备製造在内的全球医疗产业的扩张对市场成长做出了重大贡献。此外，食品业专注于延长保质期和确保食品安全，这导致抗菌塑胶在包装材料中的采用。 2020 年《食品控制》发表的一项研究指出，抗菌包装可以将生鲜食品的保质期延长 25-50%。研究强调，含有银奈米粒子的抗菌薄膜可抑制细菌生长并更长时间地维持食品品质。然而，将抗菌剂添加到塑胶中的高成本限制了市场的成长。此外，某些抗菌剂（例如银奈米颗粒和三氯生）的使用因其潜在毒性而引起环境问题，阻碍了市场成长。相反，开拓环保且可持续的抗菌解决方案有望解决环境问题并吸引具有环保意识的消费者和行业，为市场成长提供有利可图的机会。此外，抗菌剂和塑胶製造技术的创新正在提高抗菌塑胶的功效和多功能性，使其对各个行业更具吸引力。

全球抗菌塑胶市场分为添加剂、塑胶、最终用途和地区。按添加剂，市场分为无机和有机。塑胶製品分为工程类、高性能类和其他类。依最终用途划分，可分为医疗、包装、汽车、消费品、建筑/施工等。按地区划分，调查涵盖北美、欧洲、亚太地区以及拉丁美洲/中东/非洲。

主要发现

从添加剂来看，有机细分市场预计到 2033 年将快速成长。

就塑胶而言，工程塑胶领域预计将在整个预测期内处于领先地位。

从最终用途来看，医疗预计将在未来几年成为主导领域。

从地区来看，抗菌塑胶预计将在亚太地区受到广泛关注。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 历史市场资料
  • 客户/消费者/原料供应商名单 - 价值链分析
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章抗菌塑胶市场：依添加剂分类

  • 市场概况
  • 无机的
  • 有机的

第五章抗菌塑胶市场：依塑胶分类

  • 市场概况
  • 工程
  • 高效能
  • 其他的

第六章抗菌塑胶市场：依应用分类

  • 市场概况
  • 医疗保健
  • 包装
  • 车
  • 消费品
  • 建筑/施工
  • 其他的

第七章抗菌塑胶市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国抗菌塑胶市场
    • 加拿大抗菌塑胶市场
    • 墨西哥抗菌塑胶市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国抗菌塑胶市场
    • 德国抗菌塑胶市场
    • 义大利抗菌塑胶市场
    • 西班牙抗菌塑胶市场
    • 英国抗菌塑胶市场
    • 其他欧洲抗菌塑胶市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国抗菌塑胶市场
    • 日本抗菌塑胶市场
    • 印度抗菌塑胶市场
    • 韩国抗菌塑胶市场
    • 澳洲抗菌塑胶市场
    • 其他亚太抗菌塑胶市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西抗菌塑胶市场
    • 南非抗菌塑胶市场
    • 沙乌地阿拉伯抗菌塑胶市场
    • 其他拉丁美洲/中东/非洲抗菌塑胶市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • INEOS Group
  • BioCote Limited
  • Lonza Group
  • Microban International
  • RTP Company, LLC
  • Avient Corporation
  • BASF SE
  • Palram Industries Ltd.
  • LyondellBasell Industries Holdings BV
  • DuPont De Nemours, Inc.
简介目录
Product Code: A05351

The antimicrobial plastics market was valued at $43.1 billion in 2023, and is projected to reach $87.4 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033.

Antimicrobial plastics are engineered materials infused with additives or coatings designed to inhibit the growth of microorganisms. Common antimicrobial agents used in these plastics include silver ions, copper, zinc, and organic compounds like triclosan and quaternary ammonium compounds. These agents disrupt microbial cell functions, leading to their destruction or inhibition of growth. The primary benefits of antimicrobial plastics include reducing the risk of infection, extending the shelf life of products, and maintaining cleanliness. They help in minimizing microbial contamination on surfaces and in products, thereby enhancing safety and hygiene.

Increase in consumer awareness about hygiene and safety, especially in the wake of the COVID-19 pandemic, has fostered the demand for antimicrobial products, which is a key factor driving the growth of the global global antimicrobial plastics market. In addition, alarming increase in prevalence of hospital-associated infections has enforced healthcare facilities to adopt antimicrobial plastics for medical devices, equipment, and surfaces to reduce infection rates. A 2018 study published in the Journal of Hospital Infection demonstrated that the use of antimicrobial surfaces in hospital settings could reduce the incidence of hospital-associated infections by up to 30%. This reduction is significant, given the fact that approximately 1.7 million patients suffer from hospital-associated infections annually in the U.S. alone. Furthermore, the expansion of the global healthcare industry, including hospitals, clinics, and medical device manufacturing, is significantly contributing toward the market growth. Moreover, the food industry is focusing on extending shelf life and ensuring food safety, which has led to the adoption of antimicrobial plastics in packaging materials. A study published in Food Control in 2020-an international journal that focuses on food safety and food quality concerns and preventative control measures that improve public health-states that antimicrobial packaging could extend the shelf life of fresh produce by 25-50%. The study highlighted that antimicrobial films containing silver nanoparticles inhibited bacterial growth, thus preserving food quality for a longer period. However, high cost associated with the incorporation of antimicrobial agents into plastics restrains the market growth. In addition, use of certain antimicrobial agents, such as silver nanoparticles and triclosan, has raised environmental concerns due to their potential toxicity, thus hampering the market growth. On the contrary, the development of eco-friendly and sustainable antimicrobial solutions addresses environmental concerns and attracts environmentally conscious consumers and industries, which is expected to offer lucrative opportunities for the market growth. Moreover, innovations in antimicrobial agents and plastic manufacturing techniques have improved the efficacy and variety of antimicrobial plastics, making them more attractive to various industries.

The global antimicrobial plastics market is segmented into additive, plastic, end use, and region. By additive, the market is classified into inorganic and organic. On the basis of plastic, it is segregated into engineering, high-performance, and others. Depending on end use, it is fragmented into healthcare, packaging, automotive, consumer goods, building & construction, and others. Region wise, it is studied across areas such as North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By additive, the organic segment is expected to witness rapid growth by 2033.

On the basis of plastic, the engineering plastics segment is anticipated to lead throughout the forecast period.

Depending on end use, healthcare is projected to emerge as a leading segment in the coming years.

Region wise, antimicrobial plastic is likely to gain high prominence in Asia-Pacific.

Competition Analysis

Competitive analysis and profiles of the major players in the global Antimicrobial Plastics Market include INEOS Group, BioCote Limited, Lonza Group, Microban International, RTP Company, LLC, Avient Corporation, BASF SE, Palram Industries Ltd., LyondellBasell Industries Holdings B.V., and DuPont de Nemours, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional country or region analysis- market size and forecast
  • Historic market data
  • List of customers/consumers/raw material suppliers- value chain analysis
  • SWOT Analysis

Key Market Segments

By Additive

  • Inorganic and
  • Organic

By Plastic

  • Engineering
  • High-Performance
  • Others

By End-Use

  • Healthcare
  • Packaging
  • Automotive
  • Consumer Goods
  • Building and Construction
  • And Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • INEOS Group
    • BioCote Limited
    • Lonza Group
    • Microban International
    • RTP Company, LLC
    • Avient Corporation
    • BASF SE
    • Palram Industries Ltd.
    • LyondellBasell Industries Holdings B.V.
    • DuPont de Nemours, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANTIMICROBIAL PLASTICS MARKET, BY ADDITIVE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Additive
  • 4.2. Inorganic And
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Organic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ANTIMICROBIAL PLASTICS MARKET, BY PLASTIC

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Plastic
  • 5.2. Engineering
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. High-Performance
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANTIMICROBIAL PLASTICS MARKET, BY END-USE

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End-use
  • 6.2. Healthcare
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Packaging
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Automotive
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Consumer Goods
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Building And Construction
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country
  • 6.7. And Others
    • 6.7.1. Key Market Trends, Growth Factors and Opportunities
    • 6.7.2. Market Size and Forecast, By Region
    • 6.7.3. Market Share Analysis, By Country

CHAPTER 7: ANTIMICROBIAL PLASTICS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Additive
    • 7.2.3. Market Size and Forecast, By Plastic
    • 7.2.4. Market Size and Forecast, By End-use
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Antimicrobial Plastics Market
      • 7.2.6.1. Market Size and Forecast, By Additive
      • 7.2.6.2. Market Size and Forecast, By Plastic
      • 7.2.6.3. Market Size and Forecast, By End-use
    • 7.2.7. Canada Antimicrobial Plastics Market
      • 7.2.7.1. Market Size and Forecast, By Additive
      • 7.2.7.2. Market Size and Forecast, By Plastic
      • 7.2.7.3. Market Size and Forecast, By End-use
    • 7.2.8. Mexico Antimicrobial Plastics Market
      • 7.2.8.1. Market Size and Forecast, By Additive
      • 7.2.8.2. Market Size and Forecast, By Plastic
      • 7.2.8.3. Market Size and Forecast, By End-use
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Additive
    • 7.3.3. Market Size and Forecast, By Plastic
    • 7.3.4. Market Size and Forecast, By End-use
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Antimicrobial Plastics Market
      • 7.3.6.1. Market Size and Forecast, By Additive
      • 7.3.6.2. Market Size and Forecast, By Plastic
      • 7.3.6.3. Market Size and Forecast, By End-use
    • 7.3.7. Germany Antimicrobial Plastics Market
      • 7.3.7.1. Market Size and Forecast, By Additive
      • 7.3.7.2. Market Size and Forecast, By Plastic
      • 7.3.7.3. Market Size and Forecast, By End-use
    • 7.3.8. Italy Antimicrobial Plastics Market
      • 7.3.8.1. Market Size and Forecast, By Additive
      • 7.3.8.2. Market Size and Forecast, By Plastic
      • 7.3.8.3. Market Size and Forecast, By End-use
    • 7.3.9. Spain Antimicrobial Plastics Market
      • 7.3.9.1. Market Size and Forecast, By Additive
      • 7.3.9.2. Market Size and Forecast, By Plastic
      • 7.3.9.3. Market Size and Forecast, By End-use
    • 7.3.10. UK Antimicrobial Plastics Market
      • 7.3.10.1. Market Size and Forecast, By Additive
      • 7.3.10.2. Market Size and Forecast, By Plastic
      • 7.3.10.3. Market Size and Forecast, By End-use
    • 7.3.11. Rest of Europe Antimicrobial Plastics Market
      • 7.3.11.1. Market Size and Forecast, By Additive
      • 7.3.11.2. Market Size and Forecast, By Plastic
      • 7.3.11.3. Market Size and Forecast, By End-use
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Additive
    • 7.4.3. Market Size and Forecast, By Plastic
    • 7.4.4. Market Size and Forecast, By End-use
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Antimicrobial Plastics Market
      • 7.4.6.1. Market Size and Forecast, By Additive
      • 7.4.6.2. Market Size and Forecast, By Plastic
      • 7.4.6.3. Market Size and Forecast, By End-use
    • 7.4.7. Japan Antimicrobial Plastics Market
      • 7.4.7.1. Market Size and Forecast, By Additive
      • 7.4.7.2. Market Size and Forecast, By Plastic
      • 7.4.7.3. Market Size and Forecast, By End-use
    • 7.4.8. India Antimicrobial Plastics Market
      • 7.4.8.1. Market Size and Forecast, By Additive
      • 7.4.8.2. Market Size and Forecast, By Plastic
      • 7.4.8.3. Market Size and Forecast, By End-use
    • 7.4.9. South Korea Antimicrobial Plastics Market
      • 7.4.9.1. Market Size and Forecast, By Additive
      • 7.4.9.2. Market Size and Forecast, By Plastic
      • 7.4.9.3. Market Size and Forecast, By End-use
    • 7.4.10. Australia Antimicrobial Plastics Market
      • 7.4.10.1. Market Size and Forecast, By Additive
      • 7.4.10.2. Market Size and Forecast, By Plastic
      • 7.4.10.3. Market Size and Forecast, By End-use
    • 7.4.11. Rest of Asia-Pacific Antimicrobial Plastics Market
      • 7.4.11.1. Market Size and Forecast, By Additive
      • 7.4.11.2. Market Size and Forecast, By Plastic
      • 7.4.11.3. Market Size and Forecast, By End-use
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Additive
    • 7.5.3. Market Size and Forecast, By Plastic
    • 7.5.4. Market Size and Forecast, By End-use
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Antimicrobial Plastics Market
      • 7.5.6.1. Market Size and Forecast, By Additive
      • 7.5.6.2. Market Size and Forecast, By Plastic
      • 7.5.6.3. Market Size and Forecast, By End-use
    • 7.5.7. South Africa Antimicrobial Plastics Market
      • 7.5.7.1. Market Size and Forecast, By Additive
      • 7.5.7.2. Market Size and Forecast, By Plastic
      • 7.5.7.3. Market Size and Forecast, By End-use
    • 7.5.8. Saudi Arabia Antimicrobial Plastics Market
      • 7.5.8.1. Market Size and Forecast, By Additive
      • 7.5.8.2. Market Size and Forecast, By Plastic
      • 7.5.8.3. Market Size and Forecast, By End-use
    • 7.5.9. Rest of LAMEA Antimicrobial Plastics Market
      • 7.5.9.1. Market Size and Forecast, By Additive
      • 7.5.9.2. Market Size and Forecast, By Plastic
      • 7.5.9.3. Market Size and Forecast, By End-use

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. INEOS Group
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. BioCote Limited
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Lonza Group
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Microban International
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. RTP Company, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Avient Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. BASF SE
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Palram Industries Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. LyondellBasell Industries Holdings B.V.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. DuPont De Nemours, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments